Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia

• KANTARJIAN HM

収録刊行物

• Blood

  Blood 101 473-475, 2003

詳細情報

• CRID: 1573387450186141696
• NII論文ID: 10018553145
• データソース種別:
  • CiNii Articles